FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Herbert Rübben

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Anatomy

Urinary Bladder

Geographic Areas

Germany

Co-author Network

Publications

TOP 3
C Niedworok; R Rossi; C Füllhase; K Jürgensen; I Rübben; Frank vom Dorp; Herbert Rübben
[Pedicled prepuce flap plasty : Results in patients with hypospadias or urethral sticture].
Axel Wetter; Karsten Beiderwellen; Andreas Bockisch; Till A Heusner; Christine Lipponer; Felix Nensa; Tobias Olbricht; Herbert Rübben; Thomas Schlosser; Thomas C Lauenstein
Simultaneous 18F choline positron emission tomography/magnetic resonance imaging of the prostate: initial results.
Marcus Schenck; Tim Schneider; Martin Stuschke; Andreas Eisenhardt; Herbert Rübben; Catarina Schenck; Roberto Rossi
Pudendal nerve block in HDR-brachytherapy patients: do we really need general or regional anesthesia?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Herbert Rübben (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: C Niedworok; R Rossi; C Füllhase; K Jürgensen; I Rübben; Frank vom Dorp; Herbert Rübben
[Pedicled prepuce flap plasty : Results in patients with hypospadias or urethral sticture].
Der Urologe. Ausg. A 2013;52(5):672-6.
2013: Axel Wetter; Karsten Beiderwellen; Andreas Bockisch; Till A Heusner; Christine Lipponer; Felix Nensa; Tobias Olbricht; Herbert Rübben; Thomas Schlosser; Thomas C Lauenstein
Simultaneous 18F choline positron emission tomography/magnetic resonance imaging of the prostate: initial results.
Investigative radiology 2013;48(5):256-62.
2013: Marcus Schenck; Tim Schneider; Martin Stuschke; Andreas Eisenhardt; Herbert Rübben; Catarina Schenck; Roberto Rossi
Pudendal nerve block in HDR-brachytherapy patients: do we really need general or regional anesthesia?
World journal of urology 2013;31(2):417-21.
2013: Stefan Tritschler; Christian G Stief; Claudius Füllhase; Alexander Roosen; Herbert Rübben
Urethral stricture: etiology, investigation and treatments.
Deutsches Ärzteblatt international 2013;110(13):220-6.
2013: Herbert Rübben
[New coeditor for Der Urologe].
Der Urologe. Ausg. A 2013;52(2):183.
2012: R Rossi Neto; Herbert Rübben; Marcus Schenck; Frank vom Dorp; J Hess
[Surgical gender reassignment in the elderly].
Der Urologe. Ausg. A 2012;51(10):1414-8.
2012: Raimund Stein; Joachim W Thüroff; Markus Hohenfellner; Sascha Pahernik; Stephan Roth; Herbert Rübben
Urinary diversion--approaches and consequences.
Deutsches Ärzteblatt international 2012;109(38):617-22.
2012: Tibor Szarvas; Frank vom Dorp; Süleyman Ergün; Tobias Jäger; H Christoph Klingler; Gero Kramer; Viktoria Laszlo; Imre Romics; Herbert Rübben
Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer.
Urology 2012;80(3):737.e13-8.
2012: Tibor Szarvas; Agnes Bánkfalvi; Frank vom Dorp; Kurt W Schmid; Bernhard B Singer; Süleyman Ergün; Jens W Fischer; Ariane Melchior-Becker; Christian Niedworok; Henning Reis; Imre Romics; Herbert Rübben
High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer.
BJU international 2012;110(6 Pt B):E308-17.
2012: I Rübben; Herbert Rübben
[Phimosis].
Der Urologe. Ausg. A 2012;51(7):1005-16.
2012: Holger Gerullis; Melanie Homburger; Daria Orzechowski; Melek Altindag; Christoph Eimer; Evangelos Georgas; Sonja Quast; Herbert Rübben; Thomas Otto
Early endoscopic detection and subsequent removal of sphincter penetrating anastomotic sutures may prevent irreversible urinary incontinence after radical prostatectomy.
Journal of endourology / Endourological Society 2012;26(7):889-94.
2012: Tibor Szarvas; Attila Szendröi; Derya Tilki; Frank vom Dorp; Viktória László; Henning Reis; Imre Romics; Herbert Rübben; Süleyman Ergün
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer.
International journal of cancer. Journal international du cancer 2012;130(12):2922-9.
2012: Marcus Schenck; Tim Schneider; Herbert Rübben; Andreas Eisenhardt
Central venous port implantations via the cephalic vein applying an intravasal electrographic control of the catheter tip position: a single-center experience of 316 cases.
World journal of urology 2012;30(3):399-404.
2012: Hedda Luise Köhling; Markus Becker; Anna Bittner; Jan Buer; Karl-Dieter Müller; Albert Wolfgang Rettenmeier; Herbert Rübben; Frank Mosel
Direct identification of bacteria in urine samples by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and relevance of defensins as interfering factors.
Journal of medical microbiology 2012;61(Pt 3):339-44.
2011: Hagen S Bachmann; Reinhard Buettner; Angelika Eggert; Andreas Eisenhardt; Lukas Heukamp; Caroline F Hilburn; Philip Kahl; Holger Nückel; Herbert Rübben; Kurt Werner Schmid; Klaus J Schmitz; Alexander Schramm; Winfried Siffert; Johannes H Schulte
Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma.
International journal of cancer. Journal international du cancer 2011;129(10):2390-9.
2011: Frank vom Dorp; T Olbricht; Tibor Szarvas; S Tschirdewahn; Herbert Rübben
[Photodynamic diagnostics of bladder carcinoma].
Der Urologe. Ausg. A 2011;50(9):1068-71.
2011: Herbert Rübben; Frank vom Dorp
[Urothelial carcinoma].
Der Urologe. Ausg. A 2011;50 Suppl 1():176-8.
2011: Andreas Eisenhardt; K H Jöckel; M Kempin; A Scherag; Herbert Rübben
[Genotype of the GNB3 C825T polymorphism, A risk factor for the development and course of prostate cancer?].
Der Urologe. Ausg. A 2011;50(9):1137-42.
2011: Christof Börgermann; S Kliner; Hans-Joachim Luboldt; A Swoboda; Herbert Rübben
[Parameters to improve the specificity of the prostate-specific antigen. Early detection of prostate cancer].
Der Urologe. Ausg. A 2011;50(9):1095-100.
2011: J Hess; R Rossi; Herbert Rübben; Tibor Szarvas; S Tschirdewahn; Frank vom Dorp
[Urothelial carcinoma of the bladder: evaluation by combined endoscopy and urine cytology: is incontrovertible assessment possible?].
Der Urologe. Ausg. A 2011;50(6):702-5.
2011: Christof Börgermann; Oskar Ketteniss; Andreas Swoboda; Frank vom Dorp; Markus Becker; Herbert Rübben
PSA quo vadis? It is reasonable to start with prostate-specific antigen testing at the age of 40!
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(6):1190-5.
2011: Tibor Szarvas; Tobias Jäger; Markus Becker; Stephan Tschirdewahn; Christian Niedworok; ilona kovalszky; Herbert Rübben; Süleyman Ergün; Frank vom Dorp
Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer.
Pathology oncology research : POR 2011;17(2):325-32.
2011: Tibor Szarvas; Frank vom Dorp; Süleyman Ergün; Herbert Rübben
Matrix metalloproteinases and their clinical relevance in urinary bladder cancer.
Nature reviews. Urology 2011;8(5):241-54.
2011: Tibor Szarvas; Bernhard B Singer; Markus Becker; Frank vom Dorp; Tobias Jäger; Attila Szendroi; Péter Riesz; Imre Romics; Herbert Rübben; Süleyman Ergün
Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer.
BJU international 2011;107(7):1069-73.
2011: Tibor Szarvas; Markus Becker; Frank vom Dorp; Jan Meschede; André Scherag; Agnes Bánkfalvi; Henning Reis; Kurt W Schmid; Imre Romics; Herbert Rübben; Süleyman Ergün
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
International journal of cancer. Journal international du cancer 2011;128(6):1486-92.
2011: S Tschirdewahn; Frank vom Dorp; Herbert Rübben; Oliver W Hakenberg
[Exfoliative urine cytology in the treatment of bladder cancer].
Der Urologe. Ausg. A 2011;50(3):292-6.
2011: Frank vom Dorp; Philip Pal; S Tschirdewahn; Roberto Rossi; Christof Börgermann; Markus Schenck; Markus Becker; Tibor Szarvas; Oliver W Hakenberg; Herbert Rübben
Correlation of pathological and cytological-cytometric grading of transitional cell carcinoma of the urinary tract.
Urologia internationalis 2011;86(1):36-40.
2011: Tibor Szarvas; F Hoffmann; M Becker; Marcus Schenck; Frank vom Dorp; Herbert Rübben; Tobias Jäger
[Plasma E-cadherin levels in urinary bladder cancer: does it improve risk stratification?].
Der Urologe. Ausg. A 2011;50(1):64-70.
2011: Frank vom Dorp; Harald Sanders; Christof Boergermann; Gerd Lümmen; Herbert Rübben; Karl H Jakobs; Martina Schmidt
Inhibition of Rho-kinase abrogates migration of human transitional cell carcinoma cells: results of an in vitro study.
Urologia internationalis 2011;86(2):220-7.
2010: R Rossi; Herbert Rübben
[Affections of the external genitalia and their management].
Der Urologe. Ausg. A 2010;49(12):1485-9.
2010: Frank vom Dorp; S Tschirdewahn; Herbert Rübben; Dieter Jocham
[Non-muscle-invasive transitional cell carcinoma. Is BCG still a necessary part of treatment?].
Der Urologe. Ausg. A 2010;49(10):1274-6.
2010: Markus Becker; Tibor Szarvas; Markus Wittschier; Frank vom Dorp; Martin Tötsch; Kurt Werner Schmid; Herbert Rübben; Süleyman Ergün
Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer.
Cancer 2010;116(19):4502-12.
2010: I Körner; Herbert Rübben
[Undescended testis: aspects of treatment].
Der Urologe. Ausg. A 2010;49(9):1199-205; quiz 1206.
2010: Mark Goepel; Ruth Kirschner-Hermanns; Annette Welz-Barth; Klaus-Christian Steinwachs; Herbert Rübben
Urinary incontinence in the elderly: part 3 of a series of articles on incontinence.
Deutsches Ärzteblatt international 2010;107(30):531-6.
2010: Frederik Roos; Herbert Rübben; Christian G Stief; M Stöckle; Joachim W Thüroff
[Surgical treatment for renal cell carcinoma].
Aktuelle Urologie 2010;41(4):252-6.
2010: Christof Börgermann; Albert Kaufmann; Herbert Sperling; Manfred Stöhrer; Herbert Rübben
The treatment of stress incontinence in men: part 2 of a series of articles on incontinence.
Deutsches Ärzteblatt international 2010;107(27):484-91.
2010: R Rossi Neto; J Hess; A Rose; Marcus Schenck; Frank vom Dorp; Herbert Rübben
[Treatment of vesico-enteric fistulae in men. Pedicled bladder flap].
Der Urologe. Ausg. A 2010;49(7):827-31.
2010: R Rossi Neto; Herbert Rübben
[Complications management in urology].
Der Urologe. Ausg. A 2010;49(7):811.
2010: Herbert Rübben
Incontinence.
Deutsches Ärzteblatt international 2010;107(24):419.
2010: R Rossi Neto; S Tschirderwahn; A Rose; Frank vom Dorp; S Tschirdewahn; Herbert Rübben
[Endoscopic management of urethral stricture].
Der Urologe. Ausg. A 2010;49(6):708, 710, 712-3.
2010: Tibor Szarvas; Markus Becker; Frank vom Dorp; Carolin Gethmann; Martin Tötsch; Agnes Bánkfalvi; Kurt W Schmid; Imre Romics; Herbert Rübben; Süleyman Ergün
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer.
Cancer science 2010;101(5):1300-8.
2010: Tobias Jäger; Markus Becker; Andreas Eisenhardt; Derya Tilki; Martin Tötsch; Kurt W Schmid; Imre Romics; Herbert Rübben; Süleyman Ergün; Tibor Szarvas
The prognostic value of cadherin switch in bladder cancer.
Oncology reports 2010;23(4):1125-32.
2010: Christof Börgermann; Frank vom Dorp; Herbert Sperling; Herbert Rübben; T Schneider
The Zeiss-loop stone extraction: minimal invasive and effective or obsolete?
World journal of urology 2010;28(2):187-92.
2009: Hagen S Bachmann; Herbert Rübben; Kurt W Schmid; Winfried Siffert; Kathrin Riemann
DNA repair gene XRCC1 polymorphisms and outcome of renal cell carcinoma in Caucasian patients.
Anticancer research 2009;29(12):5131-5.
2009: Christof Börgermann; A Swoboda; Hans-Joachim Luboldt; Frank vom Dorp; Herbert Rübben
The f/t-PSA ratio in diagnosis of in-patients and out-patients: a unitary cutoff value is not useful!
World journal of urology 2009;27(5):581-5.
2009: C Niedworok; V Rembrink; O W Hakenberg; Christof Börgermann; R Rossi; T Schneider; M Becker; Tibor Szarvas; C von Ostau; A Swoboda; Herbert Rübben; Frank vom Dorp
[The value of urinary cytology in the diagnosis of high grade urothelial tumors].
Der Urologe. Ausg. A 2009;48(9):1018, 1020-2, 1024.
2009: Christof Börgermann; Frank vom Dorp; R Rossi; Marcus Schenck; H-J Luboldt; Herbert Rübben
[Informed consent for patients on early recognition of prostate carcinoma is insufficient].
Der Urologe. Ausg. A 2009;48(9):997-8, 1000-1.
2009: Michael J Mathers; Herbert Sperling; Herbert Rübben; Stephan Roth
The undescended testis: diagnosis, treatment and long-term consequences.
Deutsches Ärzteblatt international 2009;106(33):527-32.
2009: S Tschirdewahn; C Boergermann; M Becker; Tibor Szarvas; Herbert Rübben; Frank vom Dorp
[Urine-based cytological diagnosis against the background of the new histopathological classification].
Der Urologe. Ausg. A 2009;48(6):615-8.
2009: M Becker; Derya Tilki; Tibor Szarvas; Herbert Rübben; Süleyman Ergün
[Urine-based markers of angiogenesis in bladder cancer].
Der Urologe. Ausg. A 2009;48(6):609-14.
2009: Frank vom Dorp; Herbert Rübben; Susanne Krege
[Free skin grafts as alternatives in reconstructive plastic surgery of the genitalia].
Der Urologe. Ausg. A 2009;48(6):637-44.
2009: Tibor Szarvas; Tobias Jäger; Falk Droste; Markus Becker; ilona kovalszky; Imre Romics; Süleyman Ergün; Herbert Rübben
Serum levels of angiogenic factors and their prognostic relevance in bladder cancer.
Pathology oncology research : POR 2009;15(2):193-201.
2009: Frank vom Dorp; C Börgermann; Marcus Schenck; M Becker; A Rose; Tibor Szarvas; Herbert Rübben
[Role of lymphadenectomy in patients with invasive urothelial carcinoma of the bladder].
Der Urologe. Ausg. A 2009;48(1):51-3.
2008: Frank vom Dorp; Christof Börgermann; A Rose; M Becker; Herbert Rübben
[Targeted therapy for metastatic bladder cancer].
Der Urologe. Ausg. A 2008;47(10):1311-4.
2008: Herbert Rübben; Mark Goepel; Richard Hautmann; M Hohenfellner; Christian G Stief
[Scientific advances in German-language research in urology. Status report on the first year of the "new era of reckoning in urology"].
Der Urologe. Ausg. A 2008;47(9):1065.
2008: Frank vom Dorp; Christof Börgermann; Tobias Jäger; M Becker; Kurt W Schmid; Herbert Rübben
[From marker expression to individual therapy of patients with bladder cancer].
Der Urologe. Ausg. A 2008;47(9):1167-70.
2007: Tobias Jäger; Herbert Rübben; Christof Börgermann
[Differential therapy of prostate cancer].
Der Internist 2007;48(12):1382-7.
2007: Christof Börgermann; K Miller; Frank vom Dorp; Tobias Jäger; Herbert Rübben
[Is there an indication for adjuvant or neoadjuvant systemic therapy in prostate cancer?].
Der Urologe. Ausg. A 2007;46(10):1385-6, 1388.
2007: Frank vom Dorp; Susanne Krege; Herbert Rübben
[Inductive systemic therapy of urological tumors with curative intent].
Der Urologe. Ausg. A 2007;46(10):1400-3.
2007: Isabella Gashaw; Oliver Dushaj; Rüdiger Behr; Katharina Biermann; Ralph Brehm; Herbert Rübben; Rainer Grobholz; Kurt W Schmid; Martin Bergmann; Elke Winterhager
Novel germ cell markers characterize testicular seminoma and fetal testis.
Molecular human reproduction 2007;13(10):721-7.
2007: A Rose; M Zeino; J Busch; J Wasem; H G Nehen; Herbert Rübben
[Incontinence in elderly patients].
Der Urologe. Ausg. A 2007;46(9):1299-300.
2007: R Rossi; T Jaeger; Christof Börgermann; C Furtkamp; R Moos Stahl; Herbert Rübben; Frank vom Dorp
[Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1].
Der Urologe. Ausg. A 2007;46(9):1145-7.
2007: Frank vom Dorp; T Jaeger; K Schmidt; W Siffert; Herbert Rübben
[Prognostic factors of urinary bladder carcinoma].
Der Urologe. Ausg. A 2007;46(9):1151.
2007: Frank vom Dorp; Christof Börgermann; Peter J Goebell; K Schmid; W Siffert; Albert W Rettenmeier; Herbert Rübben
[Urinary tract tumor registry].
Der Urologe. Ausg. A 2007;46(9):1139-40.
2007: Herbert Sperling; Susanne Krege; Gerd Lümmen; Herbert Rübben
[Testicular perfusion injury. Cytokines and cell adhesion molecules in humans].
Der Urologe. Ausg. A 2007;46(9):1033-40.
2007: Y Busch; Frank vom Dorp; Marcus Schenck; R Rossi; J Witschier; Herbert Rübben
[Effect of disturbing factors on the specificity of exfoliative urinary cytology].
Der Urologe. Ausg. A 2007;46(9):1141-4.
2007: Peter J Goebell; Herbert Rübben; G Müller; Albert W Rettenmeier
[The "proteomics forum". Interdisciplinary proteome research by the Essen University Clinic].
Der Urologe. Ausg. A 2007;46(9):1157-60.
2007: Marcus Schenck; Christof Börgermann; Frank vom Dorp; M Groneberg; Y Busch; Alexander Carpinteiro; Barbara Wilker; S Keitsch; S Moyrer; Kurt W Schmid; M Stuschke; Herbert Rübben; Erich Gulbins
[Proapoptotic antibodies as new therapeutic agents for tumor treatment].
Der Urologe. Ausg. A 2007;46(9):1262-5.
2007: Tobias Jäger; Tibor Szarvas; Frank vom Dorp; Christof Börgermann; Marcus Schenck; Kurt W Schmid; Herbert Rübben
[Use of silicon chip technology to detect protein-based tumor markers in bladder cancer].
Der Urologe. Ausg. A 2007;46(9):1152-6.
2007: Kathrin Riemann; L Becker; H Struwe; Herbert Rübben; Andreas Eisenhardt; Winfried Siffert
Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer.
International journal of clinical pharmacology and therapeutics 2007;45(8):423-30.
2007: Gerd Lümmen; Herbert Rübben; T Schneider; Herbert Sperling
[Prevention of osteoporosis--important for the urologist?].
Der Urologe. Ausg. A 2007;46(6):651-5.
2007: Marcus Schenck; Christof Börgermann; Tobias Jäger; Frank vom Dorp; Herbert Sperling; Herbert Rübben; Gerd Lümmen
[Immunotherapy of metastatic renal cell carcinoma with interleukin-2, interferon-alpha2a and erythropoietin-beta].
Der Urologe. Ausg. A 2007;46(5):528-34.
2007: Tobias Jäger; Andreas Eisenhardt; Herbert Rübben; Gerd Lümmen
[Does cigarette smoking influence the survival of patients with prostate cancer?].
Der Urologe. Ausg. A 2007;46(4):397-400.
2007: Philipp A Lang; Marcus Schenck; Jan P Nicolay; Jan Ulrich Becker; Daniela S Kempe; Adrian Lupescu; Saisudha Koka; Kerstin Eisele; Barbara A Klarl; Herbert Rübben; Kurt W Schmid; Klaus Mann; Sibylle Hildenbrand; Harald Hefter; Stephan M Huber; Thomas Wieder; Andreas Erhardt; Dieter Häussinger; Erich Gulbins; Florian Lang
Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide.
Nature medicine 2007;13(2):164-70.
2007: Christof Börgermann; Frank vom Dorp; Susanne Krege; Herbert Rübben
[The management of cutaneous metastases].
Der Urologe. Ausg. A 2007;46(1):56-8.
2007: Frank vom Dorp; Christof Börgermann; Herbert Rübben
[Palliative therapy concepts for patients with urothelial cancer of the urinary bladder].
Der Urologe. Ausg. A 2007;46(1):54-5.
2006: Kathrin Riemann; Lucie Becker; Henrike Struwe; Holger Nückel; Ulrich Dührsen; Hakan Alakus; Günther Winde; Markus Neuhäuser; Herbert Rübben; Klaus J Schmitz; Jeremias Wohlschlaeger; Kurt W Schmid; Winfried Siffert
No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia.
Pharmacogenetics and genomics 2006;16(11):783-8.
2006: Christof Börgermann; M Sieverding; P Fornara; Markus Graefen; Peter Hammerer; A Semjonow; F Schröder; Herbert Rübben
[PSA 2010--the beginning of a new era in early detection of prostate cancer].
Der Urologe. Ausg. A 2006;45 Suppl 4():127-33.
2006: I Körner; A Reuss; U Kuhn; Helmut Wiedemayer; D Stolke; Jörg Pförtner; F A Löer; W Rösch; Herbert Rübben
[Myelomeningocele--"the next years..."].
Der Urologe. Ausg. A 2006;45 Suppl 4():209-13.
2006: A Rose; Herbert Sperling; J Steffens; Gerd Lümmen; B Hauffa; D Rohrmann; S Conrad; P Hoyer; Herbert Rübben
[Multimodal therapy of cryptorchism].
Der Urologe. Ausg. A 2006;45 Suppl 4():214-8.
2006: Peter J Goebell; Frank vom Dorp; C Rödel; D Frohneberg; J W Thüroff; Dieter Jocham; Christian G Stief; S Roth; Ruth Knüchel; K W Schmidt; Ingo Kausch; Dirk Zaak; C Wiesner; K Miller; R Sauer; Herbert Rübben
[Noninvasive and invasive bladder cancer: diagnostics and treatment].
Der Urologe. Ausg. A 2006;45(7):873-84; quiz 885.
2006: Peter J Goebell; Frank vom Dorp; Herbert Rübben
[Value of systemic chemotherapy in bladder cancer].
Der Urologe. Ausg. A 2006;45(5):586, 588-90, 592-3.
2006: I Körner; C Schlüter; H Lax; Herbert Rübben; C Radmayr
[Health-related quality of life in children with spina bifida].
Der Urologe. Ausg. A 2006;45(5):620-5.
2006: Ulrich H Frey; Gerd Lümmen; Tobias Jäger; Karl-Heinz Jöckel; Kurt W Schmid; Herbert Rübben; Norbert Müller; Winfried Siffert; Andreas Eisenhardt
The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):759-63.
2005: Herbert Sperling; Andreas Eisenhardt; M Becker; Herbert Rübben
[Therapy for infertile couples].
Der Urologe. Ausg. A 2005;44(10):1147-53.
2005: Andreas Eisenhardt; Winfried Siffert; Dieter Rosskopf; Michael Musch; Max Mosters; Ulla Roggenbuck; Karl-Heinz Jöckel; Herbert Rübben; Gerd Lümmen
Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer.
World journal of urology 2005;23(4):279-86.
2005: Herbert Sperling; Gerd Lümmen; Susanne Krege; Herbert Rübben
[Use of free dermal grafts in urology].
Der Urologe. Ausg. A 2005;44(7):751-5.
2005: Susanne Krege; Herbert Rübben
[Lymphadenectomy for testicular cancer. Diagnostic and prognostic significance as well as therapeutic benefit].
Der Urologe. Ausg. A 2005;44(6):652-6.
2005: Marcus Schenck; Gerd Lümmen; M Stuschke; Kurt W Schmid; Herbert Rübben
[Principle problems of lymph node surgery].
Der Urologe. Ausg. A 2005;44(6):605-7.
2005: Herbert Sperling; Gerd Lümmen; Herbert Rübben
[Use of lubricants in urology. Indications and results].
Der Urologe. Ausg. A 2005;44(6):662-6.
2005: Ulrich H Frey; Andreas Eisenhardt; Gerd Lümmen; Herbert Rübben; Karl-Heinz Jöckel; Kurt W Schmid; Winfried Siffert
The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(4):871-7.
2005: Andreas Eisenhardt; Ulrich H Frey; Monika Tack; Dieter Rosskopf; Gerd Lümmen; Herbert Rübben; Winfried Siffert
Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer.
European urology 2005;47(1):111-7.
2004: HJ Luboldt; P Fornara; L Weissbach; M Wirth; W Lorenz; Herbert Rübben
Systematic development of a guideline for early detection of prostate cancer: the German way in the evidence gap.
European urology 2004;46(6):725-30.
2004: Susanne Krege; Martina Kinzig; Fritz Sörgel; R Baschek; M C Michel; Herbert Rübben
Absorption of intravesically applied drugs: comparison of normal and ileal augmented rabbit bladder.
The Journal of urology 2004;172(5 Pt 1):2045-50.
2004: Herbert Sperling; R Rossi; Gerd Lümmen; Herbert Rübben
[Testosterone and the prostate].
Der Urologe. Ausg. A 2004;43(9):1092-6.
2004: Gerd Lümmen; Marcus Schenck; Christof Börgermann; Andreas Eisenhardt; Frank vom Dorp; Herbert Sperling; Herbert Rübben
[Inhaled immunotherapy for pulmonary metastases of renal cell cancer].
Der Urologe. Ausg. A 2004;43(4):457-61.
2004: Peter J Goebell; Cristina M Villanueva; Albert W Rettenmeier; Herbert Rübben; Manolis Kogevinas
Environmental exposure, chlorinated drinking water, and bladder cancer.
World journal of urology 2004;21(6):424-32.
2003: T Schneider; Herbert Rübben; M C Michel
[The medication-induced dysfunction of the urinary bladder].
Der Urologe. Ausg. A 2003;42(12):1588-93.
2003: Thomas Otto; Julia Suhr; S Krege; Herbert Rübben
[Therapy of advanced penis carcinoma].
Der Urologe. Ausg. A 2003;42(11):1466-9.
2003: Gerd Lümmen; Herbert Rübben
[Chemotherapy in the elderly].
Der Urologe. Ausg. A 2003;42(11):1436-44.
2003: T Otto; P J Goebell; Herbert Rübben
Perioperative Chemotherapy in Advanced Bladder Cancer - Part II: Adjuvant Treatment.
Onkologie 2003;26(5):484-8.
2003: P J Goebell; T Otto; Herbert Rübben
Perioperative chemotherapy in advanced bladder cancer: part I. Neoadjuvant treatment.
Onkologie 2003;26(4):361-5.
2003: Andreas Eisenhardt; Herbert Sperling; Ekkehard Hauck; Hartmut Porst; Christian G Stief; Herbert Rübben; Norbert Müller; Winfried Siffert
ACE gene I/D and NOS3 G894T polymorphisms and response to sildenafil in men with erectile dysfunction.
Urology 2003;62(1):152-7.
2003: Herbert Sperling; Gerd Lümmen; Tim Schneider; Herbert Rübben
[New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
Herz 2003;28(4):314-24.
2003: T Schneider; Herbert Sperling; Marcus Schenck; U Schneider; Herbert Rübben
Treatment of penile curvature--how to combine the advantages of simple plication and the Nesbit-procedure by superficial excision of the tunica albuginea.
World journal of urology 2003;20(6):350-5.
2003: Andreas Eisenhardt; D Arntzen; S Conrad; W Westenfelder; Herbert Sperling; P F Hoyer; Herbert Rübben
[Occurrence, diagnostics and therapeutic management of hydronephrosis in pediatric patients in Germany].
Der Urologe. Ausg. A 2003;42(4):538-46.
2003: Herbert Rübben; K Schalkhäuser; J Wolff; HJ Luboldt
[German Cancer Society e.V. S3 guideline for PSA determination in diagnosis of prostatic carcinoma].
Onkologie 2003;26(1):88-9.
2003: Gerd Lümmen; Herbert Rübben
G-protein-coupled receptors, cell motility and proliferation.
Urologia internationalis 2003;71(1):1-7.
2002: Thomas Otto; Julia Suhr; S Krege; Peter J Goebell; M Wishahi; U W Bier; R Kimmig; Herbert Rübben
Surgical treatment of disseminated peritoneal metastases from urological cancer: results from a prospective study.
BJU international 2002;90(9):823-7.
2002: Gerd Lümmen; Herbert Sperling; T Schneider; Thomas Otto; Herbert Rübben
[Urothelial carcinoma. Role of G-protein coupled receptors in cell movement and proliferation].
Der Urologe. Ausg. A 2002;41(4):353-61.
2002: Herbert Rübben; Gerd Lümmen
[Tumors in the elderly].
Der Urologe. Ausg. A 2002;41(4):333-7.
2002: Gerd Lümmen; Herbert Sperling; Andreas Eisenhardt; Frank vom Dorp; Thomas Otto; Herbert Rübben
Influence of pertussis toxin on superficial bladder carcinoma in rats.
Urological research 2002;30(3):199-203.
2002: Peter J Goebell; Thomas Otto; Julia Suhr; Herbert Rübben
Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.
The Journal of urology 2002;168(1):72-5.
2002: Mark Goepel; Josef A Hoffmann; Maria Piro; Herbert Rübben; Martin C Michel
Prevalence and physician awareness of symptoms of urinary bladder dysfunction.
European urology 2002;41(3):234-9.
2002: Axel Bex; Thomas Otto; Gerd Lümmen; Herbert Rübben
Phase II study of repeated single 24-hour infusion of low-dose 5-fluorouracil for palliation in symptomatic hormone-refractory prostate cancer.
Urologia internationalis 2002;69(4):273-7.
2001: Herbert Rübben; Thomas Otto
[Locally advanced or metastatic bladder carcinoma. Current aspects of therapy].
Der Urologe. Ausg. A 2001;40(6):464-7.
2001: C von Ostau; Susanne Krege; M Hartmann; Herbert Rübben
Metachronous contralateral germ cell tumor 7 years after management of testicular intraepithelial neoplasia by chemotherapy and multiple control biopsies.
Scandinavian journal of urology and nephrology 2001;35(5):430-1.
2001: Susanne Krege; Axel Bex; Gerd Lümmen; Herbert Rübben
Male-to-female transsexualism: a technique, results and long-term follow-up in 66 patients.
BJU international 2001;88(4):396-402.
2001: Mark Goepel; L Dinh; A Mitchell; Rafael F Schäfers; Herbert Rübben; M C Michel
Do saw palmetto extracts block human alpha1-adrenoceptor subtypes in vivo?
The Prostate 2001;46(3):226-32.
2001: HJ Luboldt; A Swoboda; Christof Börgermann; P Fornara; Herbert Rübben
Clinical usefulness of free PSA in early detection of prostate cancer.
Onkologie 2001;24(1):33-7.
2001: HJ Luboldt; A Bex; A Swoboda; J Hüsing; Herbert Rübben
Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.
European urology 2001;39(2):131-7.
2001: T Schneider; Herbert Sperling; Gerd Lümmen; J Syllwasschy; Herbert Rübben
Does penile size in younger men cause problems in condom use? a prospective measurement of penile dimensions in 111 young and 32 older men.
Urology 2001;57(2):314-8.
2001: Axel Bex; Bernd Wullich; V Endris; Thomas Otto; K Rembrink; Michael Stöckle; Herbert Rübben
Comparison of the malignant phenotype and genotype of the human androgen-independent cell line DU 145 and a subline derived from metastasis after orthotopic implantation in nude mice.
Cancer genetics and cytogenetics 2001;124(2):98-104.
2001: Thomas Otto; S Krege; Julia Suhr; Herbert Rübben
Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial.
Urology 2001;57(1):55-9.
2001: Susanne Krege; V Rembrink; Christof Börgermann; T Otto; Herbert Rübben
Docetaxel and ifosfamide as second line treatment for patients with advanced or metastatic urothelial cancer after failure of platinum chemotherapy: a phase 2 study.
The Journal of urology 2001;165(1):67-71.
2000: Herbert Sperling; Gerd Lümmen; C Schmidt; Herbert Rübben
Cryptorchidism: fowler-stephens procedure or autotransplantation-a new experimental model.
Urology 2000;56(5):886-90.
2000: HJ Luboldt; J Hüsing; Jens E Altwein; K H Bichler; D Czaja; P Fornara; K H Jöckel; K Schalkhäuser; L Weissbach; M Wirth; Herbert Rübben
[Early detection of prostatic carcinoma in urologic practice with digital rectal examination and prostate-specific antigen. Early Detection Project Group].
Der Urologe. Ausg. A 2000;39(4):330-3.
2000: Axel Bex; HJ Luboldt; T Sudermann; K Rembrink; Thomas Otto; Herbert Rübben
Influence of linomide on local tumor growth and metastasis of the human hormone-resistant prostate cancer cell line PC3 in an orthotopic model.
European urology 2000;37(5):628-33.
1999: Thomas Otto; Axel Bex; Gerd Lümmen; Herbert Rübben
Influence of interferon-alpha2b (IFN-alpha2b) on the prevention of locally advanced bladder carcinoma in mice.
Urological research 1999;27(6):489-92.
1999: Thomas Otto; Gerd Lümmen; T Kälble; Franz Recker; Susanne Krege; Axel Bex; F Noll; Herbert Rübben
Intravesical therapy with pertussis toxin before radical cystectomy in patients with bladder cancer: a Phase I study.
Urology 1999;54(3):458-60.
1999: Sebastian Virchow; N Ansorge; Dieter Rosskopf; Herbert Rübben; Winfried Siffert
The G protein beta3 subunit splice variant Gbeta3-s causes enhanced chemotaxis of human neutrophils in response to interleukin-8.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(1):27-32.
1999: Thomas Otto; Herbert Rübben
[Lymphatic metastases in bladder carcinoma. Is radical cystectomy indicated?].
Der Urologe. Ausg. A 1999;38(4):323-5.
1999: Herbert Sperling; Martin C Michel; Herbert Rübben
[Sildenafil (Viagra). Tolerance, contraindications, drug interactions].
Der Urologe. Ausg. A 1999;38(2):124-7.
1999: HJ Luboldt; Jens E Altwein; K H Bichler; D Czaja; J Hüsing; P Fornara; K H Jöckel; G Lübben; K Schalkhäuser; L Weissbach; M Wirth; Herbert Rübben
[Early recognition of prostate carcinoma. Initial results of a prospective multicenter study in Germany. Project Group for Early Detection DGU-BDU Laboratory diagnosis Professional Circle].
Der Urologe. Ausg. A 1999;38(2):114-23.
1999: Thomas Otto; Gerd Lümmen; A Be; Herbert Rübben; Avraham Raz
Tumor cell motility. A novel therapeutic target in bladder carcinoma, experimental and clinical results.
Advances in experimental medicine and biology 1999;462():469-76.
1999: Herbert Sperling; Gerd Lümmen; HJ Luboldt; Herbert Rübben
[Secondary erectile dysfunction. Is oral medication in the diagnostic phase indicated?].
Der Urologe. Ausg. A 1999;38(1):56-9.
1999: Mark Goepel; Susanne Krege; P Portgys; Herbert Rübben
[Urological diagnosis in children with myelomeningocele].
Der Urologe. Ausg. A 1999;38(1):10-3.
1998: Sebastian Virchow; N Ansorge; Herbert Rübben; G Siffert; Winfried Siffert
Enhanced fMLP-stimulated chemotaxis in human neutrophils from individuals carrying the G protein beta3 subunit 825 T-allele.
FEBS letters 1998;436(2):155-8.
1998: Gerd Lümmen; Herbert Sperling; Axel Bex; Thomas Otto; Herbert Rübben
Modern concepts in the therapy of urinary tract (kidney, ureter, bladder and prostate) tumours.
Pharmacological research : the official journal of the Italian Pharmacological Society 1998;38(3):151-64.
1998: Axel Bex; Herbert Rübben
[Therapy of hormone refractory prostatic carcinoma].
Der Urologe. Ausg. A 1998;37(2):159-61.
1998: Gerd Lümmen; Herbert Sperling; HJ Luboldt; Thomas Otto; Herbert Rübben
Granulocyte-macrophage colony-stimulating factor and interferon-alpha 2B in patients with advanced renal cell carcinoma.
Urologia internationalis 1998;61(4):215-9.
1998: Gerd Lümmen; Herbert Sperling; HJ Luboldt; Thomas Otto; Herbert Rübben
Phase II trial of titanocene dichloride in advanced renal-cell carcinoma.
Cancer chemotherapy and pharmacology 1998;42(5):415-7.
1997: Gerd Lümmen; Sebastian Virchow; Ulrich Rümenapp; Martina Schmidt; Thomas Wieland; Thomas Otto; Herbert Rübben; Karl H Jakobs
Identification of G protein-coupled receptors potently stimulating migration of human transitional-cell carcinoma cells.
Naunyn-Schmiedeberg's archives of pharmacology 1997;356(6):769-76.
1997: Thomas Otto; Axel Bex; Susanne Krege; P H Walz; Herbert Rübben
Paclitaxel-based second-line therapy for patients with advanced chemotherapy-resistant bladder carcinoma (M1): a clinical Phase II study.
Cancer 1997;80(3):465-70.
1997: Thomas Otto; Susanne Krege; Mark Goepel; R Baschek; Herbert Rübben
[Long-term outcome of surgical therapy of metastatic non-seminomatous germ cell tumor in advanced tumor stages].
Der Urologe. Ausg. A 1997;36(4):339-42.
1997: M Böhm; I Wieland; K Schütze; Herbert Rübben
Microbeam MOMeNT: non-contact laser microdissection of membrane-mounted native tissue.
The American journal of pathology 1997;151(1):63-7.
1997: M Böhm; H Kirch; Thomas Otto; Herbert Rübben; I Wieland
Deletion analysis at the DEL-27, APC and MTS1 loci in bladder cancer: LOH at the DEL-27 locus on 5p13-12 is a prognostic marker of tumor progression.
International journal of cancer. Journal international du cancer 1997;74(3):291-5.
1997: Thomas Otto; Axel Bex; U Schmidt; Avraham Raz; Herbert Rübben
Improved prognosis assessment for patients with bladder carcinoma.
The American journal of pathology 1997;150(6):1919-23.
1997: T Otto; Susanne Krege; B Otto; Mark Goepel; Herbert Rübben
[Therapy with mitomycin C, folic acid and 5-fluorouracil in treatment of metastatic, refractory urinary bladder carcinoma--phase II study].
Der Urologe. Ausg. A 1997;36(3):243-7.
1997: Gerd Lümmen; Herbert Sperling; Herbert Rübben
[Burkitt lymphoma as a rare cause of hydronephrosis].
Der Urologe. Ausg. A 1997;36(3):239-42.
1997: Mark Goepel; Herbert Sperling; Manfred Stöhrer; Thomas Otto; Herbert Rübben
Management of neurogenic fecal incontinence in myelodysplastic children by a modified continent appendiceal stoma and antegrade colonic enema.
Urology 1997;49(5):758-61.
1997: Gerd Lümmen; Herbert Sperling; M Pietsch; Thomas Otto; Herbert Rübben
[Treatment and follow-up of patients with squamous epithelial carcinoma of the penis].
Der Urologe. Ausg. A 1997;36(2):157-61.
1997: Mark Goepel; A Senge; Thomas Otto; Herbert Rübben
[Long-term results of wall stent implantation in benign prostatic hyperplasia and high risk status].
Der Urologe. Ausg. A 1997;36(2):151-6.
1997: Mark Goepel; A Wittmann; Herbert Rübben; MC Michel
Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate.
Urological research 1997;25(3):199-206.
1997: M Böhm; I Wieland; C Stinhöfer; Thomas Otto; Herbert Rübben
Detection of loss of heterozygosity in the APC tumor suppressor gene in nonpapillary renal cell carcinoma by microdissection and polymerase chain reaction.
Urological research 1997;25(3):161-5.
1997: Thomas Otto; Sebastian Virchow; C Fuhrmann; Fritz Steinberg; Christian Streffer; M Goepel; Herbert Rübben
Detection of vital germ cell tumor cells in short-term cell cultures of primary tumors and of retroperitoneal metastasis--clinical implications.
Urological research 1997;25(2):121-4.
1996: Susanne Krege; G Giani; R Meyer; Thomas Otto; Herbert Rübben
A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating Clinics.
The Journal of urology 1996;156(3):962-6.
1996: Susanne Krege; Mark Goepel; M Meyer-Schwickerath; Thomas Otto; Herbert Rübben
[Are their individual decisions for urinary diversion? Indications and results of 200 consecutive patients].
Der Urologe. Ausg. A 1996;35(4):291-6.
1996: Mark Goepel; B Lettgen; Thomas Otto; Herbert Rübben
[Pediatric ureteral ureteral outlet obstruction and obstructive megaureter: observation or operation?].
Der Urologe. Ausg. A 1996;35(2):91-6.
1996: Thomas Otto; K Rembrink; Mark Goepel; Susanne Krege; M Meyer-Schwiekerath; Herbert Rübben
[Therapy of hormone refractory prostate carcinoma with mitoxantrone. A clinical phase II study].
Der Urologe. Ausg. A 1996;35(2):142-5.
1996: Gerd Lümmen; Mark Goepel; S Möllhoff; A Hinke; Thomas Otto; Herbert Rübben
Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma.
The Journal of urology 1996;155(2):455-8.
1996: Mark Goepel; Franz Recker; Thomas Otto; Susanne Krege; Herbert Rübben
Results of postchemotherapy adjunctive retroperitoneal lymph node dissection in non-seminomatous germ cell cancer patients.
Urologia internationalis 1996;57(4):209-12.
1996: Herbert Sperling; D Kröpfl; Herbert Rübben
[Endoscopic therapy of ectopic ureterocele].
Der Urologe. Ausg. A 1996;35(1):57-61.
1996: Mark Goepel; Thomas Otto; D Kröpfl; Herbert Rübben
Recent considerations for hypospadias repair: results of 252 operations from 1985 to 1990.
European urology 1996;29(1):63-6.
1996: Franz Recker; Mark Goepel; Thomas Otto; Susanne Krege; M Wernli; P Stucki; R Tscholl; Herbert Rübben
An intra-operative seminal and prostate emission test as a control for nerve-sparing procedures in primary and secondary retroperitoneal lymphadenectomy.
British journal of urology 1996;77(1):133-7.
1995: Herbert Sperling; B Batke; Gerd Lümmen; D Propping; T Katzorke; F B Kolodziej; Herbert Rübben
[MESA (microsurgical epididymal sperm aspiration) and IVF (in vitro fertilization). A therapy concept in treatment of male infertility].
Der Urologe. Ausg. A 1995;34(5):409-12.
1995: T Otto; Mark Goepel; Franz Recker; Herbert Rübben
[Principles of tumor invasion and metastasis].
Der Urologe. Ausg. A 1995;34(3):208-11.
1995: Thomas Otto; M Goepel; HJ Luboldt; Herbert Rübben
[Cytokine therapy of metastatic renal cell carcinoma].
Der Urologe. Ausg. A 1995;34(3):200-3.
1995: Manfred Stöhrer; A Kramer; Mark Goepel; D Löchner-Ernst; D Kruse; Herbert Rübben
Bladder auto-augmentation--an alternative for enterocystoplasty: preliminary results.
Neurourology and urodynamics 1995;14(1):11-23.
1994: D Kröpfl; M Meyer-Schwickerath; S Fey; Herbert Rübben
[Treatment of complicated recurrent hypospadias].
Der Urologe. Ausg. A 1994;33(6):490-6.
1994: Thomas Otto; W Birchmeier; U Schmidt; A Hinke; J Schipper; Herbert Rübben; Avraham Raz
Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas.
Cancer research 1994;54(12):3120-3.
1994: Thomas Otto; Mark Goepel; S M Enzwi; M Meyer-Schwickerath; Herbert Rübben
Motility- and adhesion factors in bladder carcinoma.
Investigative urology (Berlin, Germany) 1994;5():80-4.
1994: K Rembrink; Thomas Otto; Mark Goepel; S M Enzawi; Herbert Rübben
E-cadherin: expression of the epithelial cell-cell-adhesion molecule in prostatic carcinoma and normal prostate.
Investigative urology (Berlin, Germany) 1994;5():24-7.
1993: Thomas Otto; Mark Goepel; Siegfried Seeber; Herbert Rübben
[Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
Der Urologe. Ausg. A 1993;32(3):189-93.
1993: Herbert Rübben; K Rembrink; T Johnston
Chemotherapy of prostatic carcinoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;126():71-88.
1993: Thomas Otto; K Rembrink; Mark Goepel; M Meyer-Schwickerath; Herbert Rübben
E-cadherin: a marker for differentiation and invasiveness in prostatic carcinoma.
Urological research 1993;21(5):359-62.
1992: D Kröpfl; Herbert Rübben
[Hypospadias--current surgical procedures].
Der Urologe. Ausg. A 1992;31(4):219-26.
1992: J Pannek; Herbert Rübben
[The development of urinary diversion].
Der Urologe. Ausg. A 1992;31(4):215-7.
1992: Thomas Otto; Herbert Rübben
[Risk-oriented classification of superficial bladder cancers].
Der Urologe. Ausg. A 1992;31(4):199-200.
1992: Axel Bex; Herbert Rübben; H J Feldmann; J Ammon
A system for focal intracavitary irradiation of bladder cancer with remote iridium-192 afterloading.
European urology 1992;21(3):245-9.
1991: Thomas Otto; Herbert Rübben
[Carcinoma in situ of the urinary bladder--definition and status of treatment].
Der Urologe. Ausg. A 1991;30(3):163-6.
1991: Mark Goepel; Herbert Rübben
[TNM-oriented therapy planning in bladder cancer].
Der Urologe. Ausg. A 1991;30(3):151-7.
1991: Herbert Rübben; D Jocham
[Therapy of superficial bladder carcinoma].
Der Urologe. Ausg. A 1991;30(1):2-9.
1990: Herbert Rübben; L Weissbach; L Knebel; F J Deutz; G Giani; C Graf-Dobberstein; R Gebhard
Adjuvant systemic chemotherapy after complete transurethral resection of superficially invasive bladder carcinoma (T1 G3-4 and T2 G2-4).
Urologia internationalis 1990;45(2):78-83.
1989: Franz Recker; Herbert Rübben; Axel Bex; Constantinos Constantinides
Morphological changes following ESWL in the rat kidney.
Urological research 1989;17(4):229-33.
1988: Franz Recker; Herbert Rübben; A Homburg; F J Deutz; H G Sieberth; W Lutzeyer
Enhancement of chemically induced bladder carcinoma by cyclosporin A.
Transplant international : official journal of the European Society for Organ Transplantation 1988;1(4):196-200.
1988: R Friedrichs; J Dohrenbusch; B Heinrichs; Herbert Rübben
Unilateral adrenal hemorrhage in forty-five-year-old woman.
Urology 1988;32(2):155-7.
1988: Herbert Rübben; W Lutzeyer; N Fischer; F Deutz; W Lagrange; G Giani
Natural history and treatment of low and high risk superficial bladder tumors.
The Journal of urology 1988;139(2):283-5.
1988: F J Deutz; Herbert Rübben; D Vorwerk; W Lutzeyer
Superselective embolization of inoperable renal carcinoma in patients with solitary kidney.
European urology 1988;15(1-2):134-8.
1987: B Schockenhoff; D Daub; D Stadermann; Herbert Rübben
Opioid analgesia in extracorporeal shock wave lithotripsy: fentanyl versus alfentanil.
European urology 1987;13(5):293-5.
1987: N Fischer; Herbert Rübben; S Hofsäss; B Forssmann; B Schockenhof; G Giani
[Painless extra-corporal shock wave lithotripsy using the HM3 Dornier lithotripter].
Der Urologe. Ausg. A 1987;26(1):29-32.
1986: B Schockenhoff; Herbert Rübben; D Daub; N Fischer
[Anesthesiologic aspects of extracorporeal shockwave lithotripsy (ESWL)].
Der Urologe. Ausg. A 1986;25(6):338-42.
1986: Herbert Rübben; B Terhorst; F J Deutz; W Lagrange; G Giani
[Various staining procedures in exfoliative urine cytology. Use in routine urology].
Der Urologe. Ausg. A 1986;25(5):302-4.
1986: R Friedrichs; Herbert Rübben; W Lutzeyer
Differential diagnosis and therapy of rare testicular tumors.
European urology 1986;12(4):217-23.
1983: Herbert Rübben; R Friedrichs; H W Stuhlsatz; S Cosma; W Lutzeyer
Quantitative analysis of glycosaminoglycans in urothelium and bladder wall of calf.
Urology 1983;22(6):655-7.
1983: Herbert Rübben; R Friedrichs; H W Stuhlsatz; W Lutzeyer
Glycosaminoglycans in urothelial carcinomas.
Urological research 1983;11(4):163-6.
1982: Herbert Rübben; F Hering; H H Dahm; W Lutzeyer
Value of exfoliative urinary cytology for differentiation between uric acid stone and tumor of upper urinary tract.
Urology 1982;20(6):571-3.
1982: Herbert Rübben; H H Dahm; W Lutzeyer
[Effect of intravesical instillation of cytostatic agents on the normal urothelium (author's transl)].
Der Urologe. Ausg. A 1982;21(2):116-7.
1982: W Lutzeyer; Herbert Rübben; H Dahm
Prognostic parameters in superficial bladder cancer: an analysis of 315 cases.
The Journal of urology 1982;127(2):250-2.
1982: Herbert Rübben; H H Dahm; W von Uelft; L Rüttgers; R Friedrichs; W Lutzeyer
Intravesical single and combination therapy in superficial bladder cancer. An experimental study.
European urology 1982;8(5):284-90.
1982: Herbert Rübben; F J Hering; G Durben; W Lutzeyer
[Value of screening for early detection of urological tumors (author's transl)].
Urologia internationalis 1982;37(1):1-18.
1981: Herbert Rübben; H H Dahm; W Lutzeyer
[Frequency of recurrences and tumor progression on superficial bladder carcinoma (author's transl)].
Der Urologe. Ausg. A 1981;20(4):211-4.